Cargando…
KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
BACKGROUND: The risk of recurrence after resection of a stage II or III colon cancer, and therefore qualification for adjuvant chemotherapy (ACT), is traditionally based on clinicopathological parameters. However, the parameters used in clinical practice are not able to accurately identify all patie...
Autores principales: | Uil, Sjoerd H., Coupé, Veerle M. H., Bril, Herman, Meijer, Gerrit A., Fijneman, Remond J. A., Stockmann, Hein B. A. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991490/ https://www.ncbi.nlm.nih.gov/pubmed/35395779 http://dx.doi.org/10.1186/s12885-022-09473-9 |
Ejemplares similares
-
MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018) -
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016) -
Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
por: den Uil, Sjoerd H., et al.
Publicado: (2019) -
Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012) -
Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)